13 January 2025
13 January 2025
The trial showed a 'clinically meaningful' and 'statistically significant' improvement when treated with therapy plus BCG, compared to BCG alone.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
GlobalData's latest report examines the business environment, challenges and trends that are going to impact the biopharmaceutical industry in 2025. Anti-obesity medications, IO drug development, and increasing costs of clinical trials will be among the most impactful industry trends for the next 12 months. Oncology will dominate the therapy landscape in 2025, but dermatology will display the highest growth.
GlobalData's latest report examines the business environment, challenges and trends that are going to impact the biopharmaceutical industry in 2025. Anti-obesity medications, IO drug development, and increasing costs of clinical trials will be among the most impactful industry trends for the next 12 months. Oncology will dominate the therapy landscape in 2025, but dermatology will display the highest growth.
GlobalData's latest report examines the business environment, challenges and trends that are going to impact the biopharmaceutical industry in 2025. Anti-obesity medications, IO drug development, and increasing costs of clinical trials will be among the most impactful industry trends for the next 12 months. Oncology will dominate the therapy landscape in 2025, but dermatology will display the highest growth.
Give your business an edge with our leading industry insights.
